Why the study?
Does pravastatin reduce coronary events in patients after myocardial infarction with average cholesterol levels?
Does pravastatin reduce coronary events in patients after myocardial infarction with average cholesterol levels?
Pravastatin provides clinical benefit in reducing coronary events for post-myocardial infarction patients even when their cholesterol levels are average.
Answers are grounded in this paper and cite their sources.
Supports broader statin use post-MI; extends secondary prevention evidence to average-cholesterol populations.
These results demonstrate that the benefit of cholesterol-lowering therapy extends to the majority of patients with coronary disease who have average cholesterol levels.
No takes yet. Share an insight, caveat, or question.
Sacks et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: